The authorization for drug take-back programs created in chapter 196, Laws of 2018 and chapter 155, Laws of 2021 shall be terminated on January 1, 2029, as provided in RCW 43.131.424.

Findings—Intent—2021 c 155: See note following RCW 69.48.010.